Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Broadcast Ads for Erectile Dysfunction Drugs Target Of House Legislation

This article was originally published in The Pink Sheet Daily

Executive Summary

“Shot across the bow” is designed to block ads during the day; will it also be the opening bell for proposals to limit DTC in the new Congress?

You may also be interested in...



Comparative Effectiveness For Erectile Dysfunction: Does Dose Size Matter?

A new AHRQ-sponsored clinical evidence report on erectile dysfunction underscores the challenges that comparative effectiveness studies in every field will soon face: There is so much left unstudied, how can CE possibly address all the medical practices we want to see improved

Comparative Effectiveness For Erectile Dysfunction: Does Dose Size Matter?

A new AHRQ-sponsored clinical evidence report on erectile dysfunction underscores the challenges that comparative effectiveness studies in every field will soon face: There is so much left unstudied, how can CE possibly address all the medical practices we want to see improved

DTC And Health Care Reform: Self-Regulation May Not Be Enough As Advertisers Brace For New Legislative Battles

Advertisers cannot rely on self-regulation to fend off legislative and regulatory threats in 2009, Coalition for Healthcare Communications Director John Kamp warned pharma brand teams, advertising agencies, and media companies attending the DTC National Congress April 15

Related Content

Topics

UsernamePublicRestriction

Register

PS069505

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel